儿科重症监护室入院时的体重变化和重症儿童的不良结果
Jae Hwa Jung1, Yoon Hee Kim2, Min Jung Kim3
1Department of Pediatrics, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Acute and critical care
|December 11, 2025
概括
在重症儿童中,急性体重变化与更糟糕的结果有关. 在儿科重症监护室入院时,体重变化更高,预测死亡率增加,无呼吸器日数减少.
科学领域:
- 儿科重症监护医药 儿科重症监护医药
- 临床结果研究研究的临床结果.
- 对患者进行监测.
背景情况:
- 身体重量因流体变化,营养,疾病类型和并发症而在重症儿童中波动.
- 急性体重变化 (WV) 是临床状态的潜在指标.
- 了解WV的影响对于儿科重症监护室 (PICU) 管理至关重要.
研究的目的:
- 调查急性体重变化 (WV) 与重症儿科患者临床结果之间的关联.
- 确定WV是否可以增强现有的死亡率预测模型.
主要方法:
- 对926名儿童患者 (1个月至18岁) 的回顾性分析,这些患者被录入PICU.
- WV定义为入院体重与正常体重之间的百分比差异.
- 评估了WV与PICU死亡率和无呼吸器日 (VFD) 的关联.
主要成果:
- 非幸存者 (8.7%) 与幸存者 (0.0%) 的中位数WV显著更高.
- 增加的WV独立预测了更高的死亡率 (HR,1.102) 和更少的VFD (OR,0.599).
- 结合儿童死亡率指数3得分的WV改善了死亡率预测 (AUC,0.888).
结论:
- 在PICU入院时,较高的体重变异性与不良结果独立相关.
- WV可以作为一个有价值的工具来补充现有的儿科重症监护死亡率预测模型.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Distribution
240
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Drug Dosing: Infants and Children
231
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
231
Variability: Analysis
421
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
The range is a simple measure of variability, indicating the difference between the highest and...
421
Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Factors Affecting Pulmonary Ventilation
2.8K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
2.8K
Acute Respiratory Failure-II
981
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
981


